Incidence increased from 10% to 12% over a decade in the analysis of a large U.S. cancer registry.
Over a recent 5-year period, there was little change in the percentages of patients who reported not having any detailed discussion with providers...
The findings underscore the need to better address nonalcoholic fatty liver disease and end-stage liver disease among individuals with diabetes....
“A substantial proportion of the mortality burden is potentially avoidable” with improved prevention and access to care.
These experts discuss the factors that incur increased risk for malignant endometrial polyps, the relationship between chronic...
The approval was based on an overall response rate of 19% in two nonrandomized trials.
The new guidelines are tailored for rheumatologists, and address diagnosis and treatment.
This is the fifth FDA approval of a trastuzumab biosimilar.
Pregnancy did not affect disease-free or overall survival, and complications were similar to the general population.